Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2014-01

Overcoming T790M-driven Acquired Resistance to EGFR-TKIs in NSCLC with Afatinib: A Case Report

Paola Bordi, Marcello Tiseo, Beatrice Bortesi [...]

Tumori Journal

Open access

Review article

First published 2024

Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Jietao Ma, Letian Huang, Chengbo Han

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2019

Second-line treatment of EGFR T790M-negative non-small cell lung cancer patients

Bin-Chi Liao, Sebastian Griesing, James Chih-Hsin Yang

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2018-12

Meeting with triumph and disaster: Osimertinib in T790M-unknown CNS progression in EGFR -mutated non-small cell lung cancer

Francesco Facchinetti, Francesca Bozzetti, Roberta Minari [...]

Tumori Journal

Open access

Research article

First published 2021

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients

Klaus Hackner, Anna Buder, Maximilian J Hochmair [...]

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2018

Turning EGFR mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors

Vera Hirsh

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025-1

Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKI

David Heredia, Laura Bolaño-Guerra, Angel Valencia-Velarde [...]

Cancer Biomarkers

Open access

Research article

First published 2023

Survival Analysis of 159 Patients With Advanced Non-Small-Cell Lung Cancer Resistant to First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

Aimin Hu, Kun Li, Hua Zheng [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2022

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

Ping-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang [...]

Therapeutic Advances in Respiratory Disease

Search results